Loris Bertazza Selected Research

RAF265

9/2015	Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells.
8/2014	The combination of RAF265, SB590885, ZSTK474 on thyroid cancer cell lines deeply impact on proliferation and MAPK and PI3K/Akt signaling pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Loris Bertazza Research Topics

Disease

15	Neoplasms (Cancer) 05/2023 - 01/2008
9	Thyroid Neoplasms (Thyroid Cancer) 01/2023 - 02/2014
4	medullary Thyroid cancer 01/2023 - 09/2015
2	Papillary Thyroid Cancer 01/2024 - 01/2022
2	Hypothyroidism 08/2023 - 01/2022
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2023 - 01/2016
2	Pheochromocytoma 02/2022 - 01/2021
2	Neoplasm Metastasis (Metastasis) 04/2019 - 10/2016
2	Adrenocortical Carcinoma 01/2019 - 10/2016
2	Lymphatic Metastasis 11/2017 - 01/2015
2	Hyperplasia 11/2017 - 12/2016
1	Graves Ophthalmopathy 10/2023
1	Diplopia (Double Vision) 10/2023
1	Tachycardia (Tachyarrhythmias) 08/2023
1	Chronic Thyroiditis 01/2022
1	Inflammation (Inflammations) 01/2021
1	Insulin Resistance 01/2021
1	Adrenal Cortex Neoplasms (Adrenocortical Cancer) 06/2019
1	Pathologic Complete Response 04/2019
1	Thyrotoxicosis 09/2018
1	Lung Neoplasms (Lung Cancer) 10/2016
1	Necrosis 09/2015
1	Colonic Neoplasms (Colon Cancer) 02/2012
1	Stomach Neoplasms (Stomach Cancer) 12/2009
1	Circulating Neoplastic Cells 03/2008

Drug/Important Bio-Agent (IBA)

5	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2023 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2014
3	MicroRNAs (MicroRNA)IBA 01/2023 - 11/2017
3	ZSTK474IBA 01/2018 - 08/2014
2	Hormones (Hormone)IBA 01/2023 - 09/2018
2	Amino Acid Transport Systems (Amino Acid Transporter)IBA 02/2022 - 01/2016
2	trans-crotonin (CTN)IBA 01/2021 - 04/2019
2	CurcuminIBA 06/2019 - 01/2018
2	Mitotane (Lysodren)FDA Link 06/2019 - 01/2019
2	RAF265IBA 09/2015 - 08/2014
2	SurvivinIBA 02/2012 - 12/2009
2	CytokinesIBA 01/2010 - 01/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010 - 01/2008
1	GlucocorticoidsIBA 10/2023
1	Methylprednisolone FDA LinkGeneric 10/2023
1	Thyroxine (Levothyroxine)FDA LinkGeneric 08/2023
1	CateninsIBA 05/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Thyroglobulin FDA Link 03/2022
1	gastric inhibitory polypeptide receptorIBA 01/2022
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2022
1	AutoantibodiesIBA 01/2022
1	ProcalcitoninIBA 01/2021
1	G(M3) GangliosideIBA 01/2021
1	CalciumIBA 01/2021
1	Carcinoembryonic AntigenIBA 04/2019
1	Amyloid (Amyloid Fibrils)IBA 04/2019
1	Complex MixturesIBA 01/2019
1	Amiodarone (Amiodarona)FDA LinkGeneric 09/2018
1	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 09/2018
1	cabozantinibIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Capsules (Microcapsules)IBA 11/2017
1	Serine (L-Serine)FDA Link 10/2016
1	Threonine (L-Threonine)FDA Link 10/2016
1	VX (EDIM)IBA 10/2016
1	reversanIBA 10/2016
1	SNS 314IBA 10/2016
1	tozasertibIBA 10/2016
1	4- (4- (N- benzoylamino)anilino)- 6- methoxy- 7- (3- (1- morpholino)propoxy)quinazolineIBA 10/2016
1	Aurora KinasesIBA 10/2016
1	Dihydroxyphenylalanine (Dopa)IBA 01/2016
1	Protein Isoforms (Isoforms)IBA 01/2016
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 10/2015
1	LigandsIBA 10/2015
1	DioxinsIBA 10/2015
1	Transcription Factors (Transcription Factor)IBA 10/2015
1	Indicators and Reagents (Reagents)IBA 01/2015
1	Mitogen-Activated Protein KinasesIBA 01/2015
1	Codon (Codons)IBA 05/2014
1	Antineoplastic Agents (Antineoplastics)IBA 01/2010
1	Tumor Biomarkers (Tumor Markers)IBA 03/2008
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2008

Therapy/Procedure

5	Therapeutics 08/2023 - 01/2008
1	Radiotherapy 10/2023
1	Thyroidectomy 02/2014